The co-expression of ERβ with ERα results in reduced ERα-mediated proliferation and invasion of breast cancer cells [11], [16], [17], [18], [19], at least in part due to ERβ's inhibition of ERα selective target gene expression. The gene discussed is ESR2; the disease is breast cancer.